16 Programs
-
Consensus or Controversy? Clinical Investigators Discuss and Debate Current Approaches to First- and Second-Line Therapy for HR-Positive Metastatic Breast Cancer
-
-
S
-
V
-
S
-
-
What Clinicians Want to Know: First-Line and Maintenance Therapy for Patients with ER-Positive HER2-Positive Metastatic Breast Cancer
-
-
I
-
V
-
I
-
-
Practical Perspectives on the Current and Future Management of Immune Thrombocytopenia — What Happened at ASH 2025?
-
-
C
-
F
-
H
-
C
-
-
H
-
H
-
-
Diabetology for the Medical Oncologist: Managing Hyperglycemia in Patients with Breast Cancer Receiving Agents Targeting the PI3K/AKT/PTEN Pathway
-
-
H
-
J
-
M
- +1
-
H
-